NEONATAL & PEDIATRIC
n n n
nRESPIRATORY CARE n
5th Edition, Walsh
n n
TEST BANK n
,Neonatal and Pediatric Respiratory Care, 5th Edition, Brian K. Walsh Test Bank
n n n n n n n n n n n
Table of Contents
n n
Chapter 1. Fetal Lung Development
n n n n
Chapter 2. Fetal Gas Exchange and Circulation
n n n n n n
Chapter 3. Antenatal Assessment and High-Risk Delivery
n n n n n n
Chapter 4. Examination and Assessment of the Neonatal and Pediatric Patient
n n n n n n n n n n
Chapter 5. Pulmonary Function Testing and Bedside Pulmonary Mechanics
n n n n n n n n
Chapter 6. Radiographic Assessment
n n n
Chapter 7. Pediatric Flexible Bronchoscopy
n n n n
Chapter 8. Invasive Blood Gas Analysis and Cardiovascular Monitoring
n n n n n n n n
Chapter 9. Noninvasive Monitoring in Neonatal and Pediatric Care
n n n n n n n n
Chapter 10. Oxygen Administration
n n n
Chapter 11. Aerosols and Administration of Inhaled Medications
n n n n n n n
Chapter 12. Airway Clearance Techniques and Hyperinflation Therapy
n n n n n n n
Chapter 13. Airway Management
n n n
Chapter 14. Surfactant Replacement Therapy
n n n n
Chapter 15. Noninvasive Mechanical Ventilation and Continuous Positive Pressure of the Neonate
n n n n n n n n n n n
Chapter 16. Noninvasive Mechanical Ventilation of the Infant and Child
n n n n n n n n n
Chapter 17. Invasive Mechanical Ventilation of the Neonate and Pediatric Patient
n n n n n n n n n n
Chapter 18. Administration of Gas Mixtures
n n n n n
Chapter 19. Extracorporeal Membrane Oxygenation
n n n n
Chapter 20. Pharmacology
n n
Chapter 21. Thoracic Organ Transplantation
n n n n
Chapter 22. Neonatal Pulmonary Disorders
n n n n
Chapter 23. Surgical Disorders in Childhood that Affect Respiratory Care
n n n n n n n n n
Chapter 24. Congenital Cardiac Defects
n n n n
Chapter 25. Pediatric Sleep-Disordered Breathing
n n n n
Chapter 26. Pediatric Airway Disorders and Parenchymal Lung Diseases
n n n n n n n n
Chapter 27. Asthma
n n
Chapter 28. Cystic Fibrosis
n n n
Chapter 29. Acute Respiratory Distress Syndrome
n n n n n
Chapter 30. Shock
n n
Chapter 31. Pediatric Trauma
n n n
Chapter 32. Disorders of the Pleura
n n n n n
Chapter 33. Neurological and Neuromuscular Disorders
n n n n n
Chapter 34. Pediatric Emergencies
n n n
Chapter 35. Home Care of the Postpartum Family
n n n n n n n
Chapter 36. Quality and Safety
n n n n
,Chapter 1: Fetal Lung Development
n n n n
Walsh: Neonatal & Pediatric Respiratory Care 5th Edition Test Bank (2020)
n n n n n n n n n n
MULTIPLE CHOICE n
1. Which of the following phases of human lung development is characterized by the formation
n n n n n n n n n n n n n
of a capillary network around airway passages?
n n n n n n n
a. Pseudoglandular
b. Saccular
c. Alveolar
d. Canalicular
ANS: D n
The canalicular phase follows the pseudoglandular phase, lasting from approximately 17
n n n n n n n n n n
weeks to 26 weeks of gestation. This phase is so named because of the appearance of vascular
n n n n n n n n n n n n n n n n n
channels, or capillaries, which begin to grow by forming a capillary network around the air
n n n n n n n n n n n n n n n
passages. During the pseudoglandular stage, which begins at day 52 and extends to week 16
n n n n n n n n n n n n n n n
of gestation, the airway system subdivides extensively and the conducting airway system
n n n n n n n n n n n n
develops, ending with the terminal bronchioles. The saccular stage of development, which
n n n n n n n n n n n n
takes place from weeks 29 to 36 of gestation, is characterized by the development of sacs that
n n n n n n n n n n n n n n n n n
later become alveoli. During the saccular phase, a tremendous increase in the potential gas-
n n n n n n n n n n n n n n
exchanging surface area occurs. The distinction between the saccular stage and the alveolar
n n n n n n n n n n n n n
stage is arbitrary. The alveolar stage stretches from 39 weeks of gestation to term. This stage
n n n n n n n n n n n n n n n n
is represented by the establishment of alveoli.
n n n n n n n
REF: pp. 3-5 n n
2. Regarding postnatal lung growth, by approximately what age do most of the alveoli that will
n n n n n n n n n n n n n n
be present in the lungs for life develop?
n n n n n n n n
a. 6 months n
b. 1 year n
c. 1.5 years n
d. 2 years n
ANS: C n
Most of the postnatal formation of alveoli in the infant occurs over the first 1.5 years of life.
n n n n n n n n n n n n n n n n n
At 2 years of age, the number of alveoli varies substantially among individuals. After 2 years of
n n n n n n n n n n n n n n n n n
age, males have more alveoli than do females. After alveolar multiplication ends, the alveoli
n n n n n n n n n n n n n n
continue to increase in size until thoracic growth is completed.
n n n n n n n n n n
REF: p. 6 n n
3. The respiratory therapist is evaluating a newborn with mild respiratory distress due to tracheal
n n n n n n n n n n n n n
stenosis. During which period of lung development did this problem develop?
n n n n n n n n n n n
, a. Embryonal
b. Saccular
c. Canalicular
d. Alveolar
ANS: A n
The initial structures of the pulmonary tree develop during the embryonal stage. Errors in
n n n n n n n n n n n n n
development during this time may result in laryngeal, tracheal, or esophageal atresia or
n n n n n n n n n n n n n
stenosis. Pulmonary hypoplasia, an incomplete development of the lungs characterized by an
n n n n n n n n n n n n
abnormally low number and/or size of bronchopulmonary segments and/or alveoli, can
n n n n n n n n n n n
develop during the pseudoglandular phase. If the fetus is born during the canalicular phase
n n n n n n n n n n n n n n
(i.e., prematurely), severe respiratory distress can be expected because the inadequately
n n n n n n n n n n n
developed airways, along with insufficient and immature surfactant production by alveolar
n n n n n n n n n n n
type II cells, gives rise to the constellation of problems known as infant respiratory distress
n n n n n n n n n n n n n n n
syndrome.
n
REF: n n p. 6 n
4. Which of the following mechanisms is (are) responsible for the possible association between
n n n n n n n n n n n n
noligohydramnios and lung hypoplasia? n n n
I. Abnormal carbohydrate metabolism n n
II. Mechanical restriction of the chest wall n n n n n
III. Interference with fetal breathing n n n
IV. Failure to produce fetal lung liquid n n n n n
a. I and III only
n n n
b. II and III only
n n n
c. I, II, and IV only
n n n n
d. II, III, and IV only
n n n n
ANS: D n
Oligohydramnios, a reduced quantity of amniotic fluid present for an extended period of time,
n n n n n n n n n n n n n
with or without renal anomalies, is associated with lung hypoplasia. The mechanisms by
n n n n n n n n n n n n n
which amniotic fluid volume influences lung growth remain unclear. Possible explanations for
n n n n n n n n n n n n
reduced quantity of amniotic fluid include mechanical restriction of the chest wall,
n n n n n n n n n n n n
interference with fetal breathing, or failure to produce fetal lung liquid. These clinical and
n n n n n n n n n n n n n n
experimental observations possibly point to a common denominator, lung stretch, as being a
n n n n n n n n n n n n n
major growth stimulant.
n n n
REF: pp. 6-7
n n
5. What is the purpose of the substance secreted by the type II pneumocyte?
n n n n n n n n n n n n
a. To increase the gas exchange surface area
n n n n n n
b. To reduce surface tension
n n n
c. To maintain lung elasticity
n n n
d. To preserve the volume of the amniotic fluid
n n n n n n n